作者
Koen F. W. Hekking,Sergio Maroto,Kees van Kekem,Frank S. Haasjes,Jack C. Slootweg,Patrick G. B. Oude Alink,Ron P. Dirks,Malvika Sardana,Marjon G. Bolster,Brian H. M. Kuijpers,Dennis Smith,Robin Doodeman,Marcel Scheepstra,Birgit Zech,Mark J. Mulvihill,Louis M. Renzetti,Lee E. Babiss,Paolo A. Centrella,Matthew Clark,John W. Cuozzo,Marie-Aude Guié,Eric A. Sigel,Sevan Habeshian,Christopher D. Hupp,Julie Liu,Heather A. Thomson,Ying Zhang,Anthony D. Keefe,Gerhard Müller,Stijn Gremmen
摘要
Evasion of apoptosis is critical for the development and growth of tumors. The pro-survival protein myeloid cell leukemia 1 (Mcl-1) is an antiapoptotic member of the Bcl-2 family, associated with tumor aggressiveness, poor survival, and drug resistance. Development of Mcl-1 inhibitors implies blocking of protein-protein interactions, generally requiring a lengthy optimization process of large, complex molecules. Herein, we describe the use of DNA-encoded chemical library synthesis and screening to directly generate complex, yet conformationally privileged macrocyclic hits that serve as Mcl-1 inhibitors. By applying a conceptual combination of conformational analysis and structure-based design in combination with a robust synthetic platform allowing rapid analoging, we optimized